Table 1 Sociodemographic and clinical characteristics of elderly women who underwent cervical screening at the CCPTC during the study period.
Characteristic | ≥ 60-year-olds (n = 1,319) | ≥ 65-year-olds (n = 700) |
|---|---|---|
Age, mean (SD) | 66.7 (6.7) | 71.2 (6.4) |
Age group, years; n (%) | ||
60 − 69 | 961 (72.9) | 342 (48.9) |
70 − 79 | 273 (20.7) | 273 (39.0) |
80–89 | 70 (5.3) | 70 (10.0) |
≥90 | 15 (1.1) | 15 (2.1) |
Age at menarche, years; mean (SD) | 16.3 (2.5) | 16.5 (2.7) |
Lifetime pregnancies, median (IQR) | 5 (3, 6) | 5 (3, 7) |
Live births, median (IQR) | 1 (0, 2) | 1 (0, 2) |
Postcoital bleeding, n (%) | 12 (0.9) | 5 (0.7) |
Abnormal vaginal discharge, n (%) | 26 (2.0) | 12 (1.7) |
Postmenopausal bleeding, n (%) | 14 (1.1) | 8 (1.1) |
Marital status, n (%) | ||
Single | 95 (7.2) | 45 (6.4) |
Has a steady partner | 14 (1.1) | 9 (1.3) |
Married | 464 (35.2) | 216 (30.9) |
Cohabitating | 11 (0.8) | 1 (0.1) |
Divorced | 136 (10.3) | 68 (9.7) |
Widowed | 469 (35.6) | 292 (41.7) |
Missing | 130 (9.9) | 69 (9.9) |
Highest education level, n (%) | ||
No formal education | 310 (23.5) | 189 (27.0) |
Elementary education | 213 (16.2) | 117 (16.7) |
Junior high education | 249 (18.9) | 121 (17.3) |
Senior high education | 155 (11.8) | 67 (9.6) |
Tertiary education | 126 (9.6) | 60 (8.6) |
Vocational/technical/other | 10 (0.8) | 7 (1.0) |
Missing | 256 (19.4) | 139 (19.9) |
Religious faith, n (%) | ||
Christian | 1,111 (84.2) | 587 (83.9) |
Islam | 39 (3.0) | 20 (2.9) |
African traditional religion | 37 (2.8) | 23 (3.3) |
Other | 6 (0.5) | 3 (0.4) |
Missing | 126 (9.6) | 67 (9.6) |
Earns income, n (%) | 833 (67.6) | 412 (58.9) |
National Health Insurance Scheme coverage, n (%) | 920 (69.8) | 481 (68.7) |
Current contraceptive use, n (%) | 19 (1.4) | 9 (1.3) |
Condom | 2 (0.1) | 0 (0.0) |
Combined oral contraceptive | 9 (0.7) | 6 (0.9) |
Progesterone containing pill | 2 (0.2) | 0 (0.0) |
Depot Provera | 3 (0.2) | 0 (0.0) |
Implant | 6 (0.5) | 3 (0.4) |
IUCD | 1 (0.1) | 1 (0.1) |
Past contraceptive use, n (%) | 278 (21.1) | 113 (16.1) |
Condom | 24 (1.8) | 8 (1.1) |
Combined oral contraceptive | 99 (7.5) | 41 (5.9) |
Progesterone containing pill | 13 (1.0) | 5 (0.7) |
Depot Provera | 82 (6.2) | 36 (5.1) |
Implant | 32 (2.4) | 13 (1.9) |
IUCD | 33 (2.5) | 14 (2.0) |
Prior (pre)cancer screening, n (%) | 127 (9.6) | 62 (8.9) |
Ever smoked, n (%) | 3 (0.2) | 1 (0.1) |
Current alcohol use, n (%) | 10 (0.8) | 5 (0.7) |
HIV test performed at screening, n (%) | 119 (9.0) | 59 (8.4) |
HIV status, n (%) | ||
Positive | 118 (9.0) | 55 (7.9) |
Negative/unknown | 1,201 (91.1) | 645 (92.1) |
Prior gynecological surgery, n (%) | 138 (10.5) | 62 (8.9) |
Existing medical condition, n (%) | 625 (47.4) | 336 (48.0) |
Hypertension, n (%) | 554 (42.0) | 313 (44.7) |
Diabetes, n (%) | 191 (14.5) | 108 (15.4) |
Asthma, n (%) | 19 (1.4) | 7 (1.0) |
Sickle cell disease, n (%) | 25 (1.9) | 10 (1.4) |
